login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Neovasc Inc (NVCN.CA) Stock News
Canada
- TSX:NVCN -
CA64065J4037
-
Common Stock
40.15
CAD
+0.23 (+0.58%)
Last: 4/10/2023, 7:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVCN.CA Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Shareholders Approve Acquisition by Shockwave Medical
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Announces German Reimbursement Renewal
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Shockwave Medical to Acquire Neovasc
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Announces Progress on COSIRA-II Clinical Trial
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Comments on European Heart Journal Publication
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc to Report Third Quarter Financial Results on November 10, 2022
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Provides Corporate Update Following Clinical Data Release
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Announces Key Events at TCT 2022
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc to Report Second Quarter Financial Results on August 11, 2022
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Announces Direct Sales Operations in United Kingdom
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc to Participate in H.C. Wainwright Global Investment Conference
3 years ago - By: Neovasc, Inc.
- Mentions:
NVCN
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
Please enable JavaScript to continue using this application.